KJT is delighted to announce the appointment of Laura McCormick, PhD as the new Vice President of Medical and Scientific Communications. Laura brings with her an impressive 24 years of biopharmaceutical experience, having made significant contributions in the fields of Medical Affairs, Medical Education, and Scientific Communications.
Laura holds a PhD in Molecular Biology and Immunology, and her career has been marked by extensive consulting work with major pharmaceutical companies. Her expertise includes guiding the publication process, shaping corporate policy, and overseeing the quality and accuracy of scientific content. Additionally, she has been instrumental in developing medical communications strategies for products across a variety of therapeutic areas.
“We are thrilled to have Laura join our team,” said Nicole Garberg, Head of Real World Evidence. “Her deep expertise and vast experience in the biopharmaceutical industry, particularly in medical and scientific communications, will be invaluable as we continue to expand our services and deliver high-quality insights to our clients.”
Throughout her career Laura has demonstrated a profound understanding of the complexities of the pharmaceutical landscape and has been a trusted advisor in the development and execution of communication strategies that resonate with scientific and medical communities, patients, and industry partners. Laura’s appointment underscores KJT’s commitment to enhancing its expertise and capabilities in the real world evidence sector, ensuring that clients receive the most informed and strategic guidance for their medical communication needs.
